| Literature DB >> 30319243 |
Anna Tomusiak-Plebanek1, Piotr Heczko1, Beata Skowron2, Agnieszka Baranowska2, Krzysztof Okoń3, Piotr J Thor2, Magdalena Strus1.
Abstract
PURPOSE: Some lactobacilli, which possess superoxide dismutase-like activity and catalase activity naturally, have strong antioxidative properties. The aim of this study was to identify such strains and check which of them play a crucial role in alleviating intestinal inflammation.Entities:
Keywords: antioxidative enzymes; inflammatory bowel diseases; mouse model; probiotic strains
Mesh:
Substances:
Year: 2018 PMID: 30319243 PMCID: PMC6167993 DOI: 10.2147/DDDT.S164559
Source DB: PubMed Journal: Drug Des Devel Ther ISSN: 1177-8881 Impact factor: 4.162
Antioxidative properties of the 25 Lactobacillus strains that were selected
| No | Strain number | Species | Origin of strain | SOD activity
| Catalase activity
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Peroxide test strip | SOD kit | Peroxide test strip | OxiSelect H2O2 Assay Kit | |||||||||||
| 0 h | 2 h | 24 h | 0 h | 2 h | 0 h | 2 h | 24 h | 0 h | 2 h | 24 h | ||||
| 1 | 707 | Healthy Gai2 transgenic mouse | 0 | 10 | 30 | 0 | 0.07 | 60 | 60 | 60 | 154.09 | 156.82 | 152.22 | |
| 2 | 711 | Healthy Gai2 transgenic mouse | 0 | 10 | 30 | 0 | 0 | 60 | 60 | 60 | 157.13 | 150.03 | 152 | |
| 3 | 712 | Healthy Gai2 transgenic mouse | 0 | 0 | 0 | 0 | 0 | 60 | 60 | 60 | 153.29 | 155.03 | 155.39 | |
| 4 | 713 | Healthy Gai2 transgenic mouse | 0 | 30 | 30 | 0.9 | 0 | 60 | 60 | 60 | 139.85 | 156.46 | 149.27 | |
| 5 | 718 | Healthy Gai2 transgenic mouse | 0 | 0 | 0 | 0 | 0 | 60 | 60 | 0 | 157.29 | 157.43 | 16.27 | |
| 6 | 720 | Healthy Gai2 transgenic mouse | 0 | 0 | 0 | 0.22 | 0 | 60 | 60 | 60 | 145.03 | 154.99 | 156.50 | |
| 7 | 725 | Healthy Gai2 transgenic mouse | 1 | 10 | 30 | 0.46 | 0 | 60 | 60 | 60 | 152.75 | 156.91 | 153.91 | |
| 8 | 726 | Healthy Gai2 transgenic mouse | 0 | 0 | 0 | 0 | 0 | 60 | 60 | 10 | 152.83 | 151.35 | 152.5 | |
| 9 | 747 | Healthy Gai2 transgenic mouse | 0 | 10 | 10 | 0.71 | 0 | 60 | 60 | 60 | 157.26 | 153.56 | 155.03 | |
| 10 | 753 | Gai2 transgenic mouse with IBD symptoms | 0 | 0 | 0 | 0 | 0 | 60 | 60 | 0 | 147.56 | 151.48 | 53.31 | |
| 11 | 771 | Gai2 transgenic mouse with IBD symptoms | 0 | 0 | 0 | 0 | 0.1 | 60 | 60 | 0 | 149.86 | 152.16 | 100.97 | |
| 12 | 788 | Gai2 transgenic mouse with IBD symptoms | 0 | 0 | 0 | 0 | 0.96 | 60 | 60 | 60 | 151.24 | 155.75 | 155.52 | |
| 13 | 795 | Gai2 transgenic mouse with IBD symptoms | 0 | 0 | 0 | 0 | 0 | 60 | 60 | 10 | 152.36 | 153.91 | 151.95 | |
| 14 | 807 | Human digestive tract – Crohn’s disease | 0 | 0 | 0 | 0 | 0 | 60 | 60 | 0 | 150.81 | 148.64 | 15.74 | |
| 16 | 907 | Human digestive tract – Crohn’s disease | 0 | 0 | 0 | 0 | 0 | 60 | 60 | 60 | 154.18 | 154 | 155.92 | |
| 17 | 917 | Human digestive tract – colitis ulcerosa | 0/1 | 10 | 30 | 0.73 | 0.82 | 60 | 60 | 60 | 156.01 | 159.58 | 151.64 | |
| 18 | 959 | Human digestive tract – colitis ulcerosa | 0 | 0 | 0 | 0 | 0 | 60 | 60 | 10 | 149.72 | 154.39 | 104.59 | |
| 19 | 989 | Human digestive tract – colitis ulcerosa | 0 | 0 | 0 | 0 | 0 | 60 | 60 | 30 | 154.59 | 155.06 | 84.32 | |
| 20 | 997 | Gai2 transgenic mouse with IBD symptoms | 0 | 0 | 0 | 0.62 | 0 | 60 | 60 | 30 | 152.22 | 155.54 | 156.41 | |
| 21 | 1,012 | Gai2 transgenic mouse with IBD symptoms | 0 | 10 | 10 | 1.4 | 0.8 | 60 | 60 | 60 | 159 | 152.75 | 151.73 | |
| 22 | 1,018 | Gai2 transgenic mouse with IBD symptoms | 0 | 0 | 0 | 0 | 0 | 60 | 60 | 10 | 152.90 | 150.94 | 156.28 | |
| 23 | PL02 | Human digestive tract – healthy person | 0 | 0 | 0 | 0 | 0 | 60 | 60 | 30 | 153.04 | 84.05 | 53.98 | |
| 24 | KL62A | Human digestive tract – healthy person | 0 | 0 | 0 | 0 | 0 | 60 | 60 | 1 | 152.97 | 100.10 | 24.90 | |
Notes: Strains with the highest antioxidative activity are indicated in bold. The experiments were run in triplicate using three replicates from pure culture and mean values were presented; SD data were negligible. The strains given in bold were selected for further animal studies.
Abbreviation: SOD, superoxide dismutase activity.
Species-specific primers used to identify Lactobacillus species (from Ref 19)
| Primer pair | Species | Primers | Target | Sequence (5′–3′) | PCR annealing temperature (°C) |
|---|---|---|---|---|---|
| 1 | Aci 16SI | 16S gene | AGCTGAACCAACAGATTCAC | 62 | |
| 2 | Cri 16SI | 16S gene | GTAATGACGTTAGGAAAGCG | 60 | |
| 3 | GasI | 16S-23S spacer | GAGTGCGAGAGCACTAAAG | 55 | |
| 4 | Joh 16SI | 16S gene | GAGCTTGCCTAGATGATTTTA | 57 | |
| 5 | Lfpr | 16S-23S spacer | GCCGCCTAAGGTGGGACAGAT | 55 | |
| 6 | PrI | 16S-23S spacer | CAGACTGAAAGTCTGACGG | 55 | |
| 7 | ZeaI | 16S-23S spacer | TGTTTAGTTTTGAGGGGACG | 58 | |
| 8 | PrI | 16S-23S spacer | CAGACTGAAAGTCTGACGG | 58 | |
| 9 | Lfpr | 16S-23S spacer | GCCGCCTAAGGTGGGACAGAT | 55 | |
| 10 | Lfpr | 16S-23S spacer | GCCGCCTAAGGTGGGACAGAT | 55 | |
| 11 | ShaI | 16S-23S spacer | GATAATCATGTAAGAAACCGC | 58 |
Figure 1Changes in the animals’ body temperature on selected study days.
Notes: Statistical significance was verified against group I (control) and considered as follows: *P<0.05; **P<0.01.
Figure 2Changes in the animals’ body mass on selected study days.
Notes: Statistical significance was verified against group I (control) and considered as follows: *P<0.05; **P<0.01.
Quantitative estimation of selected bacterial populations cultured from feces of animals from groups I, II, III, and IV
| Day | The global number of bacteria | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group I (control group) | ||||||||||||||
| 0 N=10 | 2.38 × 10 | 2.38 × 10 | 8.53 × 10 | 1.52 × 10 | 7.5 × 10 | 5.56 × 10 | 1.98 × 10 | 0 | 0 | |||||
| 23 N=8 | 2.75 × 10 | 2.38 × 10 | 1.28 × 10 | 1.1 × 10 | 3.1 × 10 | 4.5 × 10 | 1.63 × 10 | 5.74 × 10 | 0 | |||||
| Group II (catalase group) | ||||||||||||||
| 0 N=10 | 2.3 × 10 | 2.3 × 10 | 1.7 × 10 | 5.6 × 10 | 1.9 × 10 | 1.6 × 10 | 3.4 × 10 | 0 | 0 | |||||
| 23 N=8 | 1.15 × 10 | 7.81 × 10 | 4.88 × 10 | 2.94 × 10 | 3.25 × 10 | 4.72 × 10 | 0 | 8.3 × 10 | 0 | |||||
| Group III (dismutase-like group) | ||||||||||||||
| 0 N=10 | 6.99 × 10 | 6.84 × 10 | 6.26 × 10 | 5.82 × 10 | 1.5 × 10 | 1.15 × 10 | 4.04 × 10 | 0 | 0 | |||||
| 23 N=9 | × 8 8.64 10 | 6.72 10 × | 5.31 × 10 | 1.41 × 10 | × 8 1.56 10 | 3.11 × 10 | 2.6 × 10 | 7.77 × 10 | 3.5 × 10 | |||||
| Group IV (mixed group) | ||||||||||||||
| 0 N=10 | 3.0 × 10 | 3.0 × 10 | 3.0 × 10 | 1.2 × 10 | 4.26 × 10 | 7.39 × 10 | 2.08 × 10 | 0 | 0 | |||||
| 23 N=4 | 4.63 × 10 | 2.83 × 10 | 2.83 × 10 | 2.0 × 10 | 1.55 × 10 | 2.44 × 10 | 0 | 7.43 × 10 | 0 |
Notes: Numbers were calculated as colony-forming unit per gram of homogenized stool. Statistical significance determined by comparison of each group to day 0:
P<0.05;
P<0.01.
Quantitative differences among populations of selected microbial groups and taxa (CFU/g) isolated from colon tissue on the 23rd day of the experiment
| Selected microbial groups | Number of bacteria (CFU/g tissue)
| Statistical significance | |||
|---|---|---|---|---|---|
| Group I | Group II | Group III | Group IV | ||
| Total bacterial population | 6.1 × 10 | 4.6 × 10 | 5.5 × 10 | 3.3 × 10 | |
| 5.9 × 10 | 3.7 × 10 | 1.6 × 10 | 4.1 × 10 | ||
| 1.5 × 10 | 6.0 × 10 | 1.4 × 10 | 3.7 × 10 | ||
| 4.4 × 10 | 3.6 × 10 | 2.2 × 10 | 4.7 × 10 | ||
| 1.5 × 10 | 6.8 × 10 | 1.2 × 10 | 2.6 × 10 | ||
| 9.9 × 10 | 2.0 × 10 | 2.6 × 10 | 2.3 × 10 | ||
| 3.0 × 10 | 0 | 6.6 × 10 | 0 | ||
| Yeasts | 1.1 × 10 | 1.2 × 10 | 3.9 × 10 | 1.4 × 10 | |
| Anaerobes | 0 | 0 | 0 | 0 | |
Notes: Statistical significance:
P<0.05;
P<0.01. A value of 0 indicates populations below 1 × 102 CFU (due to the limit of the viable count method).
Abbreviation: CFU, colony-forming unit.
Histopathological examination of inflammatory changes in the intestinal tissues of the tested mice
| Group/number of mice in the group | Granulocytic infiltration in the intestinal wall | Granulocytic exudation in the lumen | Presence of crypt abscesses | The total number of points | Average number of points | SD | Comments |
|---|---|---|---|---|---|---|---|
| I/1 | 0 | 0 | 0 | 0 | 0.1 | 0.353 | – |
| I/2 | 0 | 0 | 0 | 0 | – | ||
| I/3 | 0 | 0 | 0 | 0 | – | ||
| I/4 | 0 | 0 | 0 | 0 | – | ||
| I/5 | 0 | 0 | 0 | 0 | – | ||
| I/6 | 1 | 0 | 0 | 1 | – | ||
| I/7 | 0 | 0 | 0 | 0 | – | ||
| I/8 | 0 | 0 | 0 | 0 | – | ||
| I/9 | Death | Death | Death | Death | Death on day 18 | ||
| I/10 | Death | Death | Death | Death | Death on day 17 | ||
| II/1 | 2 | 2 | 2 | 6 | 4.75 | 1.112 | – |
| II/2 | – | – | – | – | Not done | ||
| II/3 | 2 | 2 | 1 | 5 | – | ||
| II/4 | 2 | 2 | 1 | 5 | – | ||
| II/5 | 2 | 2 | 2 | 6 | – | ||
| II/6 | 1 | 1 | 1 | 3 | – | ||
| II/7 | 2 | 1 | 1 | 4 | – | ||
| II/8 | 2 | 1 | 1 | 4 | – | ||
| II/9 | Death | Death | Death | Death | Death on day 13 | ||
| II/10 | Death | Death | Death | Death | Death on day 20 | ||
| III/1 | 2 | 2 | 0 | 4 | 2.75 | 1.164 | – |
| III/2 | 1 | 1 | 0 | 2 | – | ||
| III/3 | 1 | 0 | 0 | 1 | – | ||
| III/4 | 1 | 1 | 0 | 2 | – | ||
| III/5 | 1 | 0 | 1 | 2 | – | ||
| III/6 | – | – | – | – | Not done | ||
| III/7 | 2 | 1 | 1 | 4 | – | ||
| III/8 | 2 | 1 | 1 | 4 | – | ||
| III/9 | 1 | 1 | 1 | 3 | – | ||
| III/10 | Death | Death | Death | Death | Death on day 22 | ||
| IV/1 | 2 | 2 | 2 | 6 | 4.8 | 1.5 | – |
| IV/2 | 1 | 2 | 1 | 4 | – | ||
| IV/3 | 1 | 1 | 1 | 3 | – | ||
| IV/4 | 2 | 2 | 2 | 6 | – | ||
| IV/5 | Death | Death | Death | Death | Death on day 5 | ||
| IV/6 | Death | Death | Death | Death | Death on day 21 | ||
| IV/7 | Death | Death | Death | Death | Death on day 22 | ||
| IV/8 | Death | Death | Death | Death | Death on day 22 | ||
| IV/9 | Death | Death | Death | Death | Death on day 22 | ||
| IV/10 | Death | Death | Death | Death | Death on day 22 |
Notes: Samples for histological evaluation were obtained at necropsy performed on day 23. Histological evaluation is reported in a 0–6 graded scale. Granulocytic infiltration in the intestinal wall: 0 – none, 1 – scanty, 2 – abundant. Granulocytic exudation in the lumen: 0 – none, 1 – sparse, 2 – profuse. Intracryptic abscesses: 0 – none, 1 – single, 2 – numerous.
Figure 3Histopathological section of intestinal walls.
Notes: (A) Normal structure of intestines in control group. H&E, 200×. (B) Significantly inflamed intestine in group II; with mixed-cellular infiltrate in the mucosa, some crypts contain micro abscesses (*). H&E, 200×. (C) Significant interstitial inflammation and micro abscesses (*) were observed in group III. H&E, 200×. (D) Group IV mice showed mild infiltrate in the lamina propria, composed chiefly of mononuclear cells. H&E, 200×.
Figure 4Enterococcus bacteria present in intracryptic abscess in intestines of group IV mice.
Notes: Nuclei of the intestinal epithelial cells stained with the fluorescent stain DAPI, and bacteria of the Enterococcus genus visualized using the Ent probe, labeled with CY3. Magnification 1,000×.